[1] 中华医学会外科学分会胆道外科学组和解放军全军肝胆外科专业委员会. 肝门部胆管癌诊断和治疗指南(2013年版). 中华外科杂志,2013,51(10):865-871. [2] Poruk KE,Pawlik TM,Weiss MJ.Perioperative management of hilar cholangi-ocarcinoma. J Gastrointest Surg,2015,19(10):1889-1899. [3] Hu HJ,Mao H,Shrestha A,et al.Prognostic factors and long term outcomes of hilar cholangiocarcinoma:A single institution experience in China. World J Gastroenterol,2016,22(8):2601-2610. [4] 中国抗癌协会. 肝门部胆管癌规范化诊治专家共识(2015). 中华肝胆外科杂志,2015,21(8):505-511. [5] 刘振国,强永乾. 螺旋CT和MRI对肝内周围型胆管癌诊断价值分析. 实用肝脏病杂志,2016,19(5):591-594. [6] Higuchi R,Yamamoto M.Indications for portal vein embolization in perihilar cholangiocarcinoma.J Hepatobiliary Pancreat Sci,2014,21(8):542-549. [7] Hartog H,Ijzermans JN,van Gulik TM,et al. Resection of perihilar cholangiocarcinoma.Surg Clin North Am,2016,96(2):247-267. [8] Khan SA,Davidson BR,Goldin RD,et al.British Society of Gastroenterology Guidelines for the diagnosis and treatment of cholangiocarcinoma:an update. Gut,2012,61(12):1657-1669. [9] Matsuyama R,Mori R,Ota Y,et al.Significance of vascular resection and reconstruction in surgery for hilar cholangiocarcino-ma:with special reference to hepatic arterial resection and reconstruction. Ann Surg Oncol,2016,23(Suppl 4):475-484. [10] Ngino M,Nimura Y,Nishio H,et al.Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma:an audit of 50 consecutive cases.Ann Surg,2010,252(1):115-123. [11] Vander Gaag NA,Kloek JJ,De bakker JK,et al. Survival analysis and prognostic nomogram for patients undergoing resection of extra hepatic cholangiocarcinoma.Ann Onc,2012,10(23):2642-2649. [12] Ribero D,Zimmitti G,Aloia TA,et al.Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocar-cinoma. J Am Coll Surg,2016,223(1):87-97. |